endocannabinoids drug
Evidence from:
primary |
all sources
Related entities (14)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| CB1 receptor | interacts_with | endocannabinoids | — | 1 |
| Chrm1 | regulates | endocannabinoids | — | 1 |
| endocannabinoids | expressed_in | brain development | — | 1 |
| endocannabinoids | interacts_with | CB1 receptor | — | 2 |
| endocannabinoids | regulates | CB1 receptor | — | 1 |
| endocannabinoids | targets | CB1 receptor | — | 1 |
| endocannabinoids | regulates | endocannabinoid system | — | 1 |
| endocannabinoids | regulates | GABA | 0.001 | 1 |
| endocannabinoids | interacts_with | GABA | 0.001 | 2 |
| endocannabinoids | regulates | HPA axis | — | 1 |
| endocannabinoids | regulates | increased appetite | — | 1 |
| endocannabinoids | regulates | long-term potentiation | — | 1 |
| endocannabinoids | associated_with | Neonatal rats | — | 1 |
| endocannabinoids | risk_factor_for | schizophrenia | — | 1 |
Mentioned in (39)
Papers in which this entity is mentioned.
- Connectome-seq: High-throughput Mapping of Neuronal Connectivity at Single-Synapse Resolution via Barcode Sequencing. (2025)
- Deterministic evolution and stringent selection during preneoplasia. (2023)
- Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. (2021)
- Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling. (2020)
- Cannabinoids Exacerbate Alcohol Teratogenesis by a CB1-Hedgehog Interaction. (2019)
- Hippocampal deficits in neurodevelopmental disorders. (2019)
- The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. (2018)
- An Update on Non-CB, Non-CB Cannabinoid Related G-Protein-Coupled Receptors. (2017)
- CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function. (2016)
- Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. (2015)
- Endocannabinoids are conserved inhibitors of the Hedgehog pathway. (2015)
- Modulation of pilocarpine-induced seizures by cannabinoid receptor 1. (2014)
- Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. (2014)
- Neuronal substrates and functional consequences of prenatal cannabis exposure. (2014)
- Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential. (2014)
- Cannabis controversies: how genetics can inform the study of comorbidity. (2014)
- Exercise and environment as an intervention for neonatal alcohol effects on hippocampal adult neurogenesis and learning. (2014)
- The impact of exposure to addictive drugs on future generations: Physiological and behavioral effects. (2014)
- Baths salts, spice, and related designer drugs: the science behind the headlines. (2014)
- Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity. (2013)
- Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. (2013)
- Synaptic effects induced by alcohol. (2013)
- Reduced expression of brain cannabinoid receptor 1 (Cnr1) is coupled with an increased complementary micro-RNA (miR-26b) in a mouse model of fetal alcohol spectrum disorders. (2013)
- Cannabinoid receptor 1 signaling in embryo neurodevelopment. (2012)
- The co-occurring use and misuse of cannabis and tobacco: a review. (2012)
- Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety. (2012)
- Genome-wide search for replicable risk gene regions in alcohol and nicotine co-dependence. (2012)
- Cholinergic modulation of synaptic integration and dendritic excitability in the striatum. (2011)
- Developmental trajectories during adolescence in males and females: a cross-species understanding of underlying brain changes. (2011)
- Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception. (2011)
- AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. (2011)
- Pharmacological treatment of cannabis dependence. (2011)
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. (2010)
- Cannabis and psychosis/schizophrenia: human studies. (2009)
- Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. (2009)
- Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons. (2008)
- Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. (2007)
- Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. (1997)
- Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. (1996)
Merged raw entities (6)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| endocannabinoids | drug | 26 | 103 |
| endocannabinoid | drug | 22 | 54 |
| ecbs | drug | 4 | 5 |
| exogenous cannabinoids | drug | 3 | 4 |
| ec | drug | 2 | 2 |
| endogenous ligands at cb receptors | drug | — | — |